Stay updated with breaking news from Although Zymeworks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, British Columbia, March 28, 2024 -- Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the...
VANCOUVER, British Columbia, Dec. 15, 2023 -- Zymeworks Inc. , a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced it is expected to be added...
VANCOUVER, British Columbia, June 26, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that it is set to join both the Russell 3000®, Ru...
Tech Stock News: Zymeworks (NASDAQ: $ZYME) Announces Participation in Upcoming Investor Conferences
2022 was a year of transformation and change:reported $412.5 million in total revenue for the year ended December 31, 2022;reported net income of $124.3 million ($1.90 per fully diluted share) for 2022 compared to net loss of $211.8 million in 2021;reported $492.2 million in cash resources as of December 31, 2022, w...